US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Phenylephrine HCl Injectable

Reason Lack of Assurance of Sterility

Wells Pharmacy Network LLC D-0331-2017
Class II · Moderate risk Terminated

Quad3

Reason Lack of Assurance of Sterility

Wells Pharmacy Network LLC D-0330-2017
Class II · Moderate risk Terminated

Ultra-Test

Reason Lack of Assurance of Sterility

Wells Pharmacy Network LLC D-0328-2017
Class II · Moderate risk Terminated

Vancomycin 10 mg/mL in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-005-35 D-0018-2017
Class II · Moderate risk Terminated

Placebo for Prednisolone Acetate 1%

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding D-0017-2017
Class II · Moderate risk Terminated

Mitomycin 0.02%

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-005-35 D-0015-2017
Class II · Moderate risk Terminated

Cefuroxime Sodium 10 mg/mL in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-007-35 D-0012-2017
Class II · Moderate risk Terminated

Brilliant Blue G 0.025% in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-008-35 D-0011-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.01% in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Leiter's Compounding NDC 70360-011-39 D-0010-2017
Class II · Moderate risk Terminated

Marcaine 0.5%

Reason Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Hospira Inc., A Pfizer Company NDC 0409-1610-50 D-0097-2017
Class II · Moderate risk Terminated

Marcaine 0.25%

Reason Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Hospira Inc., A Pfizer Company NDC 0409-1587-50 D-0096-2017
Class II · Moderate risk Terminated

Desoximetasone Cream USP

Reason Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Taro Pharmaceuticals, Inc. NDC 51672-1271-7 D-0117-2017
Class II · Moderate risk Terminated

Desoximetasone Cream USP

Reason Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Taro Pharmaceuticals, Inc. NDC 51672-1270-7 D-0116-2017
Class II · Moderate risk Terminated

Tri-Mix 18/1/10

Reason Lack of Assurance of Sterility; medication was sterilized with a recalled filter

The Apothecary Shoppe LLC D-0004-2017